Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 21, 2023
Infectious complications among CD19 CAR-T cell therapy recipients: A single-center experienceBryan Walker, Andrea J Zimmer, Erica J Stohs, et al.
International Journal of MS Care|December 21, 2018
Impact of Shared Decision Making on Disease-Modifying Drug Adherence in Multiple SclerosisAliza Ben-Zacharia, Meagan Adamson, Allison Boyd, et al.
Journal of Biomedical Nanotechnology|January 31, 2020
Co-Loading of Isoniazid-Grafted Phthalocyanine-in-Cyclodextrin and Rifampicin in Crude Soybean Lecithin Liposomes: Formulation, Spectroscopic and Biological CharacterizationChristian Isalomboto Nkanga, Michael Roth, Roderick Bryan Walker, et al.
Experimental Parasitology|May 30, 2008
The use of fluorescent fatty acid analogs as labels in trematode experimental infectionsDevon B Keeney, Clément Lagrue, Kim Bryan-Walker, et al.
Open Forum Infectious Diseases|December 25, 2023
Long-Acting Cabotegravir/Rilpivirine Concentrations in Combination With Intravenous Rifampin: A Case ReportShawnalyn W Sunagawa, Joshua P Havens, Anthony Podany, et al.
Molecules (Basel, Switzerland)|July 24, 2021
Enhancement of Biological and Pharmacological Properties of an Encapsulated Polyphenol: CurcuminBwalya Angel Witika, Pedzisai Anotida Makoni, Scott Kaba Matafwali, et al.
International Journal of MS Care|September 18, 2023
Factors Associated With Disease-Modifying Therapy Adherence and Persistence in Multiple Sclerosis: A Scoping Literature ReviewAliza Bitton Ben-Zacharia, Bryan Walker, Amy Perrin Ross, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 4, 2021
Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosisJiwon Oh, Bryan Walker, Gavin Giovannoni, et al.
Neurodegenerative Disease Management|January 12, 2022
Side effects that occurred early in people with multiple sclerosis during the first year of treatment with cladribine tablets: a plain language summaryJiwon Oh, Bryan Walker, Gavin Giovannoni, et al.
Frontiers in Immunology|January 10, 2022
Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine TabletsGavin Giovannoni, Patricia K Coyle, Patrick Vermersch, et al.
Pageof 3